<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>39(6)</volume><submitter>Donnez J</submitter><funding>NCATS NIH HHS</funding><funding>Theramex</funding><funding>ObsEva</funding><funding>National Institute for Health Research (NIHR)</funding><funding>Kissei</funding><funding>Gedeon Richter and Theramex</funding><journal>Human reproduction (Oxford, England)</journal><pagination>1208-1221</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11144970</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3).</pubmed_title><pmcid>PMC11144970</pmcid><funding_grant_id>5/4/150/5</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><pubmed_authors>Boolell M</pubmed_authors><pubmed_authors>Patel A</pubmed_authors><pubmed_authors>Bestel E</pubmed_authors><pubmed_authors>Carmona Herrera F</pubmed_authors><pubmed_authors>Horne A</pubmed_authors><pubmed_authors>Paszkowski M</pubmed_authors><pubmed_authors>Petraglia F</pubmed_authors><pubmed_authors>Taylor H</pubmed_authors><pubmed_authors>Renner SP</pubmed_authors><pubmed_authors>Donnez O</pubmed_authors><pubmed_authors>Dolmans MM</pubmed_authors><pubmed_authors>Donnez J</pubmed_authors><pubmed_authors>Becker C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3).</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-05-29T09:49:44.808Z</modification><creation>2026-04-08T04:10:44.4Z</creation></dates><accession>S-EPMC11144970</accession><cross_references><pubmed>38648863</pubmed><doi>10.1093/humrep/deae076</doi></cross_references></HashMap>